Literature DB >> 24254926

The fallacy of the medical model and the dangers of psychotropic drugs as a mode of treatment for mental disorders.

V D Sanua1.   

Abstract

With the decline of psychoanalytic thinking since the 50's and the 60's, mental disorders have been attributed to organic factors. This has been influenced by Social Darwinism, a belief in the survival of the fittest. The implication of such a philosophy is that social intervention is not the appropriate approach for the treatment of mental aberrations. The source of the problem lies within the individual. For example, schizophrenia has been attributed to brain anomalies, chemical imbalances or to the inheritance of genetic factors. To this day, in spite of the research efforts in that direction, the pursuit of these findings were proven to be illusive. Nevertheless, the search continues with a complete neglect of social factors. One problem is that writers disagreeing with this philosophy, find it difficult to publish their dissenting views. Since the source of the problem is within the individual, aberrations should be treated with drugs. However the efficacy of these drugs have not yet been confirmed and instead have been causing a lot of physical problems for patients. It is unfortunate that a number of influential clinical psychologists have adopted the medical model and are trying to obtain by legislation "prescription privileges" for psychologists. The author believes that this trend could be destructive to the profession of psychology, since it will weaken if not destroy the humanistic approach in the treatment of the mentally ill.

Entities:  

Year:  1996        PMID: 24254926     DOI: 10.1007/BF02262743

Source DB:  PubMed          Journal:  J Prim Prev        ISSN: 0278-095X


  30 in total

1.  A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives.

Authors:  I I Gottesman; J Shields
Journal:  Schizophr Bull       Date:  1976       Impact factor: 9.306

2.  Effect on behavior in humans with the administration of taraxein.

Authors:  R G HEATH; S MARTENS; B E LEACH; M COHEN; C ANGEL
Journal:  Am J Psychiatry       Date:  1957-07       Impact factor: 18.112

Review 3.  A critique of the scientific status of biological psychiatry.

Authors:  A Pam
Journal:  Acta Psychiatr Scand Suppl       Date:  1990

Review 4.  The current status of neuroleptic therapy.

Authors:  J M Kane
Journal:  J Clin Psychiatry       Date:  1989-09       Impact factor: 4.384

5.  Risk factors for neuroleptic malignant syndrome. A case-control study.

Authors:  P E Keck; H G Pope; B M Cohen; S L McElroy; A A Nierenberg
Journal:  Arch Gen Psychiatry       Date:  1989-10

Review 6.  Tardive dyskinesia: barriers to the professional recognition of an iatrogenic disease.

Authors:  P Brown; S C Funk
Journal:  J Health Soc Behav       Date:  1986-06

Review 7.  Can antidepressants cause mania and worsen the course of affective illness?

Authors:  T A Wehr; F K Goodwin
Journal:  Am J Psychiatry       Date:  1987-11       Impact factor: 18.112

8.  The fate of the mentally ill in Germany during the Third Reich.

Authors:  J E Meyer
Journal:  Psychol Med       Date:  1988-08       Impact factor: 7.723

9.  Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.

Authors:  M S Buchsbaum; D H Ingvar; R Kessler; R N Waters; J Cappelletti; D P van Kammen; A C King; J L Johnson; R G Manning; R W Flynn; L S Mann; W E Bunney; L Sokoloff
Journal:  Arch Gen Psychiatry       Date:  1982-03

10.  Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.

Authors:  H Szechtman; C Nahmias; E S Garnett; G Firnau; G M Brown; R D Kaplan; J M Cleghorn
Journal:  Arch Gen Psychiatry       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.